郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine.

期刊：Drug design, development and therapy发表年份：2019作者：Béla Kiss; Zsolt Némethy; Károly Fazekas; Dalma Kurkó; István Gyertyán; Katalin Sághy; István Laszlovszky; Bence Farkas; Norbert Kirschner; Etelka Bolf-Terjéki; Ottilia Balázs; Balázs Lendvai
阅读更多 →

药效评价Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies.

期刊：Journal of controlled release : official journal of the Controlled Release Society发表年份：2019作者：K Varini; P Lécorché; R Sonnette; F Gassiot; B Broc; M Godard; M David; A Faucon; K Abouzid; G Ferracci; J Temsamani; M Khrestchatisky; G Jacquot
阅读更多 →

药效评价Enzyme-free release of adhered cells from standard culture dishes using intermittent ultrasonic traveling waves.

期刊：Communications biology发表年份：2019作者：Yuta Kurashina; Chikahiro Imashiro; Makoto Hirano; Taiki Kuribara; Kiichiro Totani; Kiyoshi Ohnuma; James Friend; Kenjiro Takemura
阅读更多 →

药效评价SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization.

期刊：Behavioural pharmacology发表年份：2019作者：Ramakrishna Nirogi; Renny Abraham; Vijay Benade; Rajesh B Medapati; Pradeep Jayarajan; Gopinadh Bhyrapuneni; NageswaraRao Muddana; Venkat R Mekala; Ramkumar Subramanian; Anil Shinde; Ramasastry Kambhampati; Venkat Jasti
阅读更多 →